ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.74
0.00%
US Tech 100
19,021.20
-0.25%
S&P 500
5,433.74
0.23%
US Dollar vs CAD
1.37616
0.13%
Bitcoin
67,153.63
0.60%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Plus Therapeutics Inc (PSTV)

  7. Plus Therapeutics Inc (PSTV) News

PSTV Plus Therapeutics Inc

2.13
0.00 (0.00%)
Pre Market
Last Updated: 07:08:27
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Plus Therapeutics Inc PSTV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 2.13 07:08:27
Open Price Low Price High Price Close Price Previous Close
2.13
more quote information »

Recent News

Date Time Source Heading
6/07/202416:02EDGAR2Form S-1 - General form for registration of securities under..
6/07/202415:02EDGAR2Form 8-K - Current report
6/07/202406:30GLOBEPlus Therapeutics Expands Management Team and Reports $3.3M..
6/05/202406:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
6/04/202416:16EDGAR2Form 8-K - Current report
5/20/202406:00EDGAR2Form 8-K - Current report
5/17/202416:00GLOBEPlus Therapeutics Announces New Employment Inducement Grants
5/15/202415:15GLOBEPlus Therapeutics Reports First Quarter 2024 Financial..
5/15/202415:01EDGAR2Form 8-K - Current report
5/15/202415:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202406:30GLOBEPlus Therapeutics to Announce First Quarter Financial..
5/10/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202416:20EDGAR2Form 8-K - Current report
5/09/202410:29GLOBEPlus Therapeutics Provides Highlights Regarding..
5/08/202416:35GLOBEPlus Therapeutics to Host Investor Call to Discuss..
5/06/202406:30GLOBEPlus Therapeutics Announces Private Placement Financing of..
4/22/202406:00GLOBEPlus Therapeutics Receives $3 Million Award Recommendation..
3/08/202415:30EDGAR2Form S-1/A - General form for registration of securities..
3/05/202415:04EDGAR2Form 8-K - Current report
3/05/202415:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/26/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202315:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/22/202315:08EDGAR2Form S-1 - General form for registration of securities under..
11/20/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/20/202306:01EDGAR2Form 8-K - Current report
11/17/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/15/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202315:55EDGAR2Form 8-K - Current report
10/31/202315:06EDGAR2Form 8-K - Current report
10/31/202315:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
9/15/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/12/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/11/202306:00GLOBEPlus Therapeutics Receives $1.9 Million Advance Payment from..
9/08/202306:00GLOBEPlus Therapeutics Enters into License Agreement for..
9/05/202306:00GLOBEPlus Therapeutics Initiates Part B of ReSPECT-LM Phase 1/2a..

Your Recent History

NASDAQ
PSTV
Plus Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved